Quantitative analysis for Pharvaris N.V. (PHVS) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Unrated (50.0). Gem alpha score: 72.0. 32 signals analyzed (27 differentiated alt-data).
PHVS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-30 | $31.14 | $29.68 | $31.01 |
| 2026-05-12 | $31.47 | $29.40 | $31.25 |
| 2026-05-22 | $31.00 | $29.51 | $29.68 |
| 2026-06-04 | $32.20 | $29.56 | $31.63 |
| 2026-06-16 | $32.28 | $30.70 | $31.46 |
| 2026-06-29 | $35.18 | $33.96 | $34.71 |
| 2026-07-10 | $36.25 | $33.97 | $35.07 |
| 2026-07-22 | $34.86 | $34.04 | $34.36 |
| 2026-08-03 | $32.82 | $31.51 | $32.25 |
| 2026-08-13 | $36.93 | $33.79 | $34.04 |
| 2026-08-25 | $38.00 | $36.69 | $37.23 |
| 2026-09-04 | $36.39 | $35.21 | $35.25 |
How Pharvaris N.V. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| MESO | Mesoblast Limited | $1.9B | — |
| BHC | Bausch Health Companies Inc. | $2.1B | 33.0 |
| LKFT | Galapagos N.V. Sponsored ADR | $1.8B | — |
| ESTA | Establishment Labs Holdings Inc. | $2.1B | — |
View all Health Care stocks by valuation and signals →
Pharvaris N.V. (PHVS) scores Unrated (50.0), with no measured dimension below 73. Its highest are analyst consensus at 90, technicals at 73, across 2 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 90 |
| technicals | 73 |
StoQuant analyzes 32 signals (27 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Pharvaris N.V. (PHVS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/PHVS"><img src="https://stoquant.com/badge/PHVS.svg" alt="Pharvaris N.V. (PHVS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.